234 related articles for article (PubMed ID: 26203639)
1. Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice.
Hou Y; Guey LT; Wu T; Gao R; Cogan J; Wang X; Hong E; Vivian Ning W; Keene D; Liu N; Huang Y; Kaftan C; Tangarone B; Quinones-Garcia I; Uitto J; Francone OL; Woodley DT; Chen M
J Invest Dermatol; 2015 Dec; 135(12):3060-3067. PubMed ID: 26203639
[TBL] [Abstract][Full Text] [Related]
2. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
Remington J; Wang X; Hou Y; Zhou H; Burnett J; Muirhead T; Uitto J; Keene DR; Woodley DT; Chen M
Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
[TBL] [Abstract][Full Text] [Related]
3. Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.
Wang X; Ghasri P; Amir M; Hwang B; Hou Y; Khalili M; Khilili M; Lin A; Keene D; Uitto J; Woodley DT; Chen M
Mol Ther; 2013 Jul; 21(7):1335-44. PubMed ID: 23670575
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa.
Woodley DT; Cogan J; Mosallaei D; Yim K; Chen M
J Dermatol Sci; 2021 Nov; 104(2):104-111. PubMed ID: 34674926
[TBL] [Abstract][Full Text] [Related]
5. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
Liao Y; Ivanova L; Sivalenka R; Plumer T; Zhu H; Zhang X; Christiano AM; McGrath JA; Gurney JP; Cairo MS
Stem Cells Transl Med; 2018 Jul; 7(7):530-542. PubMed ID: 29745997
[TBL] [Abstract][Full Text] [Related]
7. Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili Z; Nguyen NT; Gorell ES; Loutit K; Khuu P; Furukawa LK; Lorenz HP; Leung TH; Keene DR; Rieger KE; Khavari P; Lane AT; Tang JY; Marinkovich MP
JAMA; 2016 Nov; 316(17):1808-1817. PubMed ID: 27802546
[TBL] [Abstract][Full Text] [Related]
8. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
9. Systemic protein therapy for recessive dystrophic epidermolysis bullosa: how far are we from clinical translation?
Hovnanian A
J Invest Dermatol; 2013 Jul; 133(7):1719-21. PubMed ID: 23760051
[TBL] [Abstract][Full Text] [Related]
10. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.
Jacków J; Titeux M; Portier S; Charbonnier S; Ganier C; Gaucher S; Hovnanian A
J Invest Dermatol; 2016 Jul; 136(7):1346-1354. PubMed ID: 26994967
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
Woodley DT; Cogan J; Hou Y; Lyu C; Marinkovich MP; Keene D; Chen M
J Clin Invest; 2017 Aug; 127(8):3028-3038. PubMed ID: 28691931
[TBL] [Abstract][Full Text] [Related]
12. Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.
Cogan J; Weinstein J; Wang X; Hou Y; Martin S; South AP; Woodley DT; Chen M
Mol Ther; 2014 Oct; 22(10):1741-52. PubMed ID: 25155989
[TBL] [Abstract][Full Text] [Related]
13. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.
Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS
Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200
[TBL] [Abstract][Full Text] [Related]
14. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa.
Woodley DT; Wang X; Amir M; Hwang B; Remington J; Hou Y; Uitto J; Keene D; Chen M
J Invest Dermatol; 2013 Jul; 133(7):1910-3. PubMed ID: 23321924
[No Abstract] [Full Text] [Related]
15. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
[TBL] [Abstract][Full Text] [Related]
16. Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa.
Bremer J; Kramer D; Eichhorn DS; Gostyński A; Diercks GFH; Jonkman MF; van den Akker PC; Pasmooij AMG
Exp Dermatol; 2019 Oct; 28(10):1153-1155. PubMed ID: 30019435
[TBL] [Abstract][Full Text] [Related]
17. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
Petrova A; Georgiadis C; Fleck RA; Allison L; McGrath JA; Dazzi F; Di WL; Qasim W
J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
[TBL] [Abstract][Full Text] [Related]
18. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing.
Woodley DT; Remington J; Huang Y; Hou Y; Li W; Keene DR; Chen M
Mol Ther; 2007 Mar; 15(3):628-35. PubMed ID: 17245357
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.
Condorelli AG; Logli E; Cianfarani F; Teson M; Diociaiuti A; El Hachem M; Zambruno G; Castiglia D; Odorisio T
Br J Dermatol; 2019 Nov; 181(5):1017-1027. PubMed ID: 30816994
[TBL] [Abstract][Full Text] [Related]
20. Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.
Supp DM; Hahn JM; Combs KA; McFarland KL; Schwentker A; Boissy RE; Boyce ST; Powell HM; Lucky AW
Cell Transplant; 2019; 28(9-10):1242-1256. PubMed ID: 31271052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]